Macrophage biomarkers scd163 and ssirp in serum predict mortality in sarcoma patients

HIGHLIGHTS

  • who: Ninna Aggerholm-Pedersen and colleagues from the Department of Oncology, Aarhus University Hospital, Palle Juul-Jensens Boulevard, Aarhus, Denmark have published the paper: Macrophage Biomarkers sCD163 and sSIRP in Serum Predict Mortality in Sarcoma Patients, in the Journal: Cancers 2023, 15, x FOR of /2023/
  • what: This study investigated the prognostic value of four serum Methods: Blood samples were taken from 152 patients with STS at the time of diagnosis; clinical data were prospectively collected. This study demonstrated that serum of immunosuppressive macrophages were prognostic for OS; when combined with well-established markers of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?